Lantern Pharma Inc. hosted a September 23, 2026 webinar focused on its Open-Medicine AI multi-agentic platform for drug development. Investors can access the replay through YouTube and Lantern Pharma’s investor website, while the accompanying presentation offers the company’s discussion materials for review.

Key Highlights

  • Lantern Pharma Inc. held a live webinar on September 23, 2026, focused on its Open-Medicine AI platform.
  • The discussion covered a multi-agentic AI platform intended for drug development.
  • A webinar replay is available through YouTube and Lantern Pharma’s investor website.

Lantern Pharma Inc. (NASDAQ: LTRN) is a Pharmaceuticals: Major company. The company hosted a live webinar on September 23, 2026, focused on its Open-Medicine AI multi-agentic platform for drug development. The presentation used during the discussion is also available as supporting material.

Open-Medicine AI Platform Discussion

The presentation used to support the webinar discussion is available alongside the event materials. That presentation covers the subject of the Open-Medicine AI platform.